Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.83 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.83 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.63 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.63 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.60 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.60 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.59 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | LCK | P06239 | 1/20 | 0.57 |
| ▸ | PPARD | Q03181 | 1/20 | 0.57 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.57 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.57 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.52 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.52 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.52 |
| ▸ | HTR2A | P28223 | 1/20 | 0.52 |
| ▸ | HTR2C | P28335 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL167273 | 1.00 | CA2 (0.83) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL10788879 | 1.00 | CA2 (0.83) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL687840 | 1.00 | CA2 (0.83) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL1704587 | 1.00 | CA2 (0.83) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| Hexane SCHEMBL4788148 | 1.00 | CA2 (0.83) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL2492860 | 1.00 | CA2 (0.83) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL17329112 | 1.00 | CA2 (0.83) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| Hexane SCHEMBL18237384 | 1.00 | CA2 (0.83) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL3003696 | 1.00 | CA2 (0.83) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL1645242 | 1.00 | CA2 (0.83) | CA2MAPK1GRIK1GRIK2SLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 567 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025108545-A1 | DELIVERY OF NUCLEOTIDES FROM INJECTABLE BIOMATERIAL | DANMARKS TEKNISKE UNIVERSITET (DK) | 2025-05-30 | — | — | WO | claimed |
| EP-4529477-A1 | POROUS EXPANDING BIOCOMPATIBLE SCAFFOLDS | Danmarks Tekniske Universitet (DK) | 2025-04-02 | — | — | EP | claimed |
| EP-3512351-B1 | COMPOSITIONS AND METHODS FOR IMPROVING TASTE OF NON-NUTRITIVE SWEETENERS | PEPSICO INC (US) | 2024-07-24 | — | — | EP | claimed |
| EP-4294375-A1 | METHODS OF LOADING EXTRACELLULAR VESICLES | Lonza Sales AG (CH) | 2023-12-27 | — | — | EP | claimed |
| WO-2023227518-A1 | POROUS EXPANDING BIOCOMPATIBLE SCAFFOLDS | DANMARKS TEKNISKE UNIVERSITET (DK) | 2023-11-30 | — | — | WO | claimed |
| EP-4282448-A1 | POROUS EXPANDING BIOCOMPATIBLE SCAFFOLDS | Danmarks Tekniske Universitet (DK) | 2023-11-29 | — | — | EP | claimed |
| US-20220339285-A1 | DISSACHARIDE FORMULATIONS FOR CONTROLLED DRUG RELEASE | TECHNICAL UNIVERSITY OF DENMARK (DK) | 2022-10-27 | — | — | US | claimed |
| WO-2022178147-A1 | METHODS OF LOADING EXTRACELLULAR VESICLES | CODIAK BIOSCIENCES, INC. (US) | 2022-08-25 | — | — | WO | claimed |
| EP-3982922-A1 | DISSACHARIDE FORMULATIONS FOR CONTROLLED DRUG RELEASE | Technical University of Denmark (DK) | 2022-04-20 | — | — | EP | claimed |
| WO-2022044591-A1 | CARBONATED BEVERAGE, METHOD FOR PREPARING FLAVOR COMPOSITION, AND METHOD FOR SUPPRESSING BUBBLES OF CARBONATED BEVERAGE | 高砂香料工業株式会社 | 2022-03-03 | — | — | WO | claimed |
| US-7465696-B2 | Lubricating base oil compositions and methods for improving fuel economy in an internal combustion engine using same | CHEVRON ORONITE COMPANY, LLC (US) | 2008-12-16 | — | — | US | claimed |
| EP-1688476-A1 | Lubricating base oil compositions and methods for improving fuel economy in an internal combustion engine using same | Chevron Oronite Company LLC (US) | 2006-08-09 | — | — | EP | claimed |
| US-20060172898-A1 | Lubricating base oil compositions and methods for improving fuel economy in an internal combustion engine using same | CHEVRON ORONITE COMPANY, LLC | 2006-08-03 | — | — | US | claimed |
| EP-1150722-B1 | IMPLANT COMPRISING CALCIUM CEMENT AND HYDROPHOBIC LIQUID | ROBERT MATHYS STIFTUNG (CH) | 2005-10-05 | — | — | EP | claimed |
| US-20050037073-A1 | Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof | ALPHARX INC. (CA) | 2005-02-17 | — | — | US | claimed |
| US-20030072798-A1 | Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof | ALPHARX INC. (CA) | 2003-04-17 | — | — | US | claimed |
| US-20020102301-A1 | Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereof | ALPHARX INC. (CA) | 2002-08-01 | — | — | US | claimed |
| EP-0508153-A2 | Solid ink compositions for thermal ink-jet printing having improved printing characteristics | Hewlett-Packard Company (US) | 1992-10-14 | — | — | EP | claimed |
| US-5065167-A | Vaporizable solid ink composition for thermal ink-jet printing | HEWLETT-PACKARD COMPANY (US) | 1991-11-12 | — | — | US | claimed |
| US-4400295-A | REACTION PRODUCT OF A FATTY ACID, AMINO ACID AND A SECONDARY COMPOUND | LOIRE COSMETICS CO., LTD. (JP) | 1983-08-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220339285-A1 | DISSACHARIDE FORMULATIONS FOR CONTROLLED DRUG RELEASE | LIPA, LIPE, CEL | CA2 648/4885MAPK1 3962/4885GRIK1 3810/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.